Drug · DIN 02446685
ZEVTERA
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 20, 2018; first marketed March 20, 2018.
- Drug Identification Number (DIN)
- 02446685
- Company (DIN owner)
- Avir Pharma IncBlainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Ceftobiprole medocaril J01DI01
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEFTOBIPROLE (CEFTOBIPROLE MEDOCARIL SODIUM) | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 30, 2017: NOC 19980New Drug Submission (NDS) · Transfer of drug identification number
- September 24, 2015: NOC 17319New Drug Submission (NDS)